Business Description
Bioxyne Ltd
NAICS : 325412
SIC : 2836
ISIN : AU000000BXN6
Compare
Compare
Traded in other countries / regions
BXN.Australia IPO Date
2000-12-14Description
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum PCC. Some of its products include Breathe Life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange, and others. The company operates in segments namely, wholesale sales, Plant-based, Manufacturing sales, and direct sales. The majority of the revenue is generated from plants based segment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.53 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -0.41 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -2.35 | |||||
| Beneish M-Score | -1.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.6 | |||||
| 3-Year Book Growth Rate | -12.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.53 | |||||
| 9-Day RSI | 63.99 | |||||
| 14-Day RSI | 62.5 | |||||
| 6-1 Month Momentum % | 140 | |||||
| 12-1 Month Momentum % | 9.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.92 | |||||
| Quick Ratio | 1.18 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 96.48 | |||||
| Days Sales Outstanding | 41.74 | |||||
| Days Payable | 89.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -47.3 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.44 | |||||
| Operating Margin % | -17.79 | |||||
| Net Margin % | -142.9 | |||||
| FCF Margin % | -43.45 | |||||
| ROE % | -184.74 | |||||
| ROA % | -137.24 | |||||
| ROIC % | -31.18 | |||||
| ROC (Joel Greenblatt) % | -128.64 | |||||
| ROCE % | -23.18 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.25 | |||||
| PB Ratio | 8.5 | |||||
| EV-to-EBIT | -20.78 | |||||
| EV-to-EBITDA | -20.78 | |||||
| EV-to-Revenue | 3.7 | |||||
| EV-to-FCF | -7.5 | |||||
| Price-to-Median-PS-Value | 0.85 | |||||
| Earnings Yield (Greenblatt) % | -4.81 | |||||
| FCF Yield % | -11.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioxyne Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 9.325 | ||
| EPS (TTM) (A$) | -0.007 | ||
| Beta | 0.57 | ||
| Volatility % | 108.6 | ||
| 14-Day RSI | 62.5 | ||
| 14-Day ATR (A$) | 0.001914 | ||
| 20-Day SMA (A$) | 0.013475 | ||
| 12-1 Month Momentum % | 9.09 | ||
| 52-Week Range (A$) | 0.004 - 0.023 | ||
| Shares Outstanding (Mil) | 2,049.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioxyne Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioxyne Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bioxyne Ltd Frequently Asked Questions
What is Bioxyne Ltd(ASX:BXN)'s stock price today?
The current price of ASX:BXN is A$0.02. The 52 week high of ASX:BXN is A$0.02 and 52 week low is A$0.00.
When is next earnings date of Bioxyne Ltd(ASX:BXN)?
The next earnings date of Bioxyne Ltd(ASX:BXN) is .
Does Bioxyne Ltd(ASX:BXN) pay dividends? If so, how much?
Bioxyne Ltd(ASX:BXN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers